Ista Pharma Gains 11% Following FDA Approval

Shares of Ista Pharmaceuticals Inc. (ISTA) are up sharply, and on 12 times its normal volume (1.65 mln today vs 131K average). The eye-care specialist announced today that its Bromday eye drop treatment — a once-daily eye drop to treat inflammation and reduce ocular pain in patients following cataract extraction — won approval from [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.